Gilead director Bluestone exercises options, sells 5,000 shares

Q: What transactions did GILD director Jeffrey Bluestone report on January 20, 2026?

Jeffrey Bluestone reported exercising options for 5,000 shares of Gilead common stock and then selling 5,000 shares on January 20, 2026. The exercise converted a non-qualified stock option into common stock, followed by a same-day sale.

Q: How many GILD shares did Jeffrey Bluestone sell and at what price?

Jeffrey Bluestone sold 5,000 shares of Gilead common stock at $123.5000 per share. These sales occurred on January 20, 2026 and followed his exercise of options for the same number of shares earlier that day.

Q: What options did Jeffrey Bluestone exercise in this GILD Form 4 filing?

He exercised a Non-qualified Stock Option for 5,000 shares of Gilead common stock at an exercise price of $67.4500 per share. The option is reported with an expiration date of May 12, 2031 and relates to common stock.

Accepted by SEC EDGAR 01/21/2026 - 04:26 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Gilead Sciences director Jeffrey Bluestone exercised non-qualified stock options for 5,000 shares of common stock at $67.4500 per share on January 20, 2026, then sold 5,000 shares at $123.5000 per share the same day under a Rule 10b5-1 trading plan adopted on February 13, 2025. After these transactions, he holds 8,920 shares of Gilead common stock directly.

Insider Trade Summary

Exercise and Sale: 5,000 shares ($280K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Bluestone Jeffrey

Role Director

Sold 5,000 shs ($618K)

Approx. gross sale proceeds $618K

Approx. exercise cost $337K

Approx. pre-tax spread $280K

Share of Position Sold 35.9%

Type	Security	Shares	Price	Value
Exercise	Non-qualified Stock Option (Right to Buy)	5,000	$0.00	$0.00
Exercise	Common Stock	5,000	$67.45	$337K
Sale	Common Stock	5,000	$123.50	$618K

Holdings After Transaction: Non-qualified Stock Option (Right to Buy) — 4,665 contracts (Direct); Common Stock — 8,920 shares (Direct)

Holdings Before and After: Non-qualified Stock Option (Right to Buy), 9,665 to 4,665 contracts (Direct); Common Stock, 8,920 to 8,920 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

F1. The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
F2. 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.

Key Figures

Options exercised: 5000.0000 shares Option exercise price: $67.4500 per share Shares sold: 5000.0000 shares +3 more

6 metrics

Options exercised 5000.0000 shares Non-qualified Stock Option exercised on 2026-01-20

Option exercise price $67.4500 per share Exercise price for Non-qualified Stock Option

Shares sold 5000.0000 shares Common Stock sale on 2026-01-20

Sale price $123.5000 per share Per-share price for Common Stock sale

Post-transaction holdings 8,920 shares Common Stock held directly after transactions

Option expiration date 2031-05-12 Expiration of Non-qualified Stock Option

Key Terms

Non-qualified Stock Option (Right to Buy), Rule 10b5-1 trading plan, Exercise or conversion of derivative security

3 terms

Non-qualified Stock Option (Right to Buy) financial

"security_title: Non-qualified Stock Option (Right to Buy)"

Rule 10b5-1 trading plan regulatory

"transactions reported ... pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did GILD director Jeffrey Bluestone report on January 20, 2026?

Jeffrey Bluestone reported exercising options for 5,000 shares of Gilead common stock and then selling 5,000 shares on January 20, 2026. The exercise converted a non-qualified stock option into common stock, followed by a same-day sale.

How many GILD shares did Jeffrey Bluestone sell and at what price?

Jeffrey Bluestone sold 5,000 shares of Gilead common stock at $123.5000 per share. These sales occurred on January 20, 2026 and followed his exercise of options for the same number of shares earlier that day.

What options did Jeffrey Bluestone exercise in this GILD Form 4 filing?

He exercised a Non-qualified Stock Option for 5,000 shares of Gilead common stock at an exercise price of $67.4500 per share. The option is reported with an expiration date of May 12, 2031 and relates to common stock.

How many GILD shares does Jeffrey Bluestone hold after these transactions?

After the reported transactions, Jeffrey Bluestone directly holds 8,920 shares of Gilead common stock. This post-transaction holding reflects his position following the January 20, 2026 option exercise and the sale of 5,000 shares.

Were Jeffrey Bluestone’s GILD transactions made under a Rule 10b5-1 trading plan?

Yes. The filing states that all reported transactions were made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025. Such pre-arranged plans allow insiders to sell shares according to preset instructions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bluestone Jeffrey

(Last)

(First)

(Middle)

333 LAKESIDE DRIVE

(Street)

FOSTER CITY

94404

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/20/2026		M⁽¹⁾		5,000	A	$67.45	13,920	D
Common Stock	01/20/2026		S⁽¹⁾		5,000	D	$123.5	8,920	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-qualified Stock Option (Right to Buy)	$67.45	01/20/2026		M⁽¹⁾			5,000	⁽²⁾	05/12/2031	Common Stock	5,000	$0	4,665	D

Explanation of Responses:

1. The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

2. 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.

Remarks:

	/s/ Edward S. Son by Power of Attorney for Jeffrey A. Bluestone	01/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR